Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

Placebo

Oral tablet every morning for 2 weeks

DRUG

Armodafinil

Three 50 mg tablets orally every morning for 2 weeks.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cephalon

INDUSTRY

lead

M.D. Anderson Cancer Center

OTHER

NCT01169753 - Nuvigil in Treatment of Cancer-Related Fatigue in Chronic Myeloid Leukemia Patients | Biotech Hunter | Biotech Hunter